Evidence map›Paper›PMID 37215970›Full record

ArticleClinical case reports2023

Recurrent malignant peritoneal mesothelioma treated by a second resection: A case report.

Takashi Miyata, Hisashi Nishiki, Yuki Shinden, Shota Motoyama, Yuta Sannomiya, Hozumi Tamezawa, Taigo Nagayama, Ryosuke Kin, Akifumi Hashimoto, Daisuke Kaida and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Takashi MiyataDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.ORCID https://orcid.org/0000-0002-0348-2637
Hisashi NishikiDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Yuki ShindenDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Shota MotoyamaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Yuta SannomiyaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Hozumi TamezawaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Taigo NagayamaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Ryosuke KinDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Akifumi HashimotoDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Daisuke KaidaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Yasuto TomitaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Naohiko NakamuraDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.ORCID https://orcid.org/0000-0002-5542-0163
Tomoharu MiyashitaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Hideto FujitaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Nobuhiko UedaDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Hiroyuki TakamuraDepartment of General and Digestive Surgery Kanazawa Medical University Hospital Kahoku Japan.
Kanazawa Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Malignant peritoneal mesothelioma, a rare and poor prognosis disease, is seldom treated surgically, especially for recurrence. However, early diagnosis and aggressive treatment of primary and recurrent tumors can achieve long-term patient survival. Abstract: Malignant peritoneal mesothelioma (MPM) is a rare and aggressive tumor, and rarely indicated for surgery, especially for recurrence. In the present case, we report a rare case who could survive long-term after two surgeries in 4 years for MPM.

Indexed as

localized mesotheliomamalignant peritoneal mesotheliomarecurrence

Identifiers

PMID37215970
PMCPMC10196420
OpenAlexW4377138374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.